Delivery Order SPE2DB20D9135-SPE2DB22FD2XL

Award Date 2/25/22
Potential Completion Date 3/18/22
Potential Value $9.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The order, valued at $11,006.95, is for the provision of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities and VA medical centers nationwide....
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a $30,691.70 firm fixed-price delivery order from the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The contract provides a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. DMS...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $3,024.30 firm fixed-price delivery order covers the supply of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical needs of military health facilities worldwide....
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) as a firm fixed-price delivery order under the SPE2DB program. The $4,716.94 contract covers the delivery of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order worth $37,224.96 under the Defense Logistics Agency's (DLA) SPE2DB program. The contract is for the prime vendor supply of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $34,995.88 firm fixed-price contract is for the supply of various pharmaceutical products, including prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The $17,614.47 firm fixed-price contract is for the prime vendor supply of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities and Department of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract, valued at $197,147.20, is for the supply of various pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $9,284.40 under the SPE2DB program administered by the Defense Logistics Agency (DLA). The contract covers the provision of a diverse range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $6,848.92 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) worth up to $499,999,999. The contract covers a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare...
  • SPE2DB20D9135
    Indefinite Delivery Contract
  • SPE2DB20D9135-SPE2DB22FD2XL
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract, valued at up to $9,473.84, is for the supply of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the diverse medical requirements of the Department of Defense (DoD) healthcare facilities. The contract does not have a set-aside designation, but DMS Pharmaceutical Group's status as a woman-owned small business has enabled the company to secure direct awards for pharmaceutical Prime Vendor programs supporting military medical facilities globally.

Generated 1/9/25, 9:23 AM